Early Vascular Aging Determined by 3-Dimensional Aortic Geometry: Genetic Determinants and Clinical Consequences
- PMID: 40671674
- PMCID: PMC12278840
- DOI: 10.1161/CIRCULATIONAHA.125.074554
Early Vascular Aging Determined by 3-Dimensional Aortic Geometry: Genetic Determinants and Clinical Consequences
Abstract
Background: Vascular aging is an important phenotype characterized by structural and geometric remodeling. Some individuals exhibit supernormal vascular aging, associated with improved cardiovascular outcomes; others experience early vascular aging, linked to adverse cardiovascular outcomes. The aorta is the artery that exhibits the most prominent age-related changes; however, the biological mechanisms underlying aortic aging, its genetic architecture, and its relationship with cardiovascular structure, function, and disease states remain poorly understood.
Methods: We developed sex-specific models to quantify aortic age on the basis of aortic geometric phenotypes derived from 3-dimensional tomographic imaging data in 2 large biobanks: the UK Biobank and the Penn Medicine BioBank. Convolutional neural network-assisted 3-dimensional segmentation of the aorta was performed in 56 104 magnetic resonance imaging scans in the UK Biobank and 6757 computed tomography scans in the Penn Medicine BioBank. Aortic vascular age index (AVAI) was calculated as the difference between the vascular age predicted from geometric phenotypes and the chronological age, expressed as a percent of chronological age. We assessed associations with cardiovascular structure and function using multivariate linear regression and examined the genetic architecture of AVAI through genome-wide association studies, followed by Mendelian randomization to assess causal associations. We also constructed a polygenic risk score for AVAI.
Results: AVAI displayed numerous associations with cardiac structure and function, including increased left ventricular mass (standardized β=0.144 [95% CI, 0.138, 0.149]; P<0.0001), wall thickness (standardized β=0.061 [95% CI, 0.054, 0.068]; P<0.0001), and left atrial maximum volume (standardized β=0.060 [95% CI, 0.050, 0.069]; P<0.0001). AVAI exhibited high genetic heritability (h2=40.24%). We identified 54 independent genetic loci (P<5×10-8) associated with AVAI, which further exhibited gene-level associations with the fibrillin-1 (FBN1) and elastin (ELN1) genes. Mendelian randomization supported causal associations between AVAI and atrial fibrillation, vascular dementia, aortic aneurysm, and aortic dissection. A polygenic risk score for AVAI was associated with an increased prevalence of atrial fibrillation, hypertension, aortic aneurysm, and aortic dissection.
Conclusions: Early aortic aging is significantly associated with adverse cardiac remodeling and important cardiovascular disease states. AVAI exhibits a polygenic, highly heritable genetic architecture. Mendelian randomization analyses support a causal association between AVAI and cardiovascular diseases, including atrial fibrillation, vascular dementia, aortic aneurysms, and aortic dissection.
Keywords: aorta; biological specimen banks; genome-wide association study.
Conflict of interest statement
Dr Chirinos is supported by NIH grants U01-TR003734, U01-TR003734-01S1, U01-HL160277, R33-HL-146390, R01-HL153646, K24-AG070459, R01-AG058969, R01-HL157108, R01-HL155599, R01-HL104106, and R01HL155764; has recently consulted for Bayer, Fukuda-Denshi, Bristol Myers Squibb, Biohaven Pharmaceuticals, Johnson & Johnson, Edwards Life Sciences, Merck, and NGM Biopharmaceuticals; received University of Pennsylvania research grants from NIH, Fukuda-Denshi, Bristol Myers Squibb, Microsoft, and Abbott; is named as inventor in a University of Pennsylvania patent for the use of inorganic nitrates/nitrites for the treatment of heart failure and preserved ejection fraction and for the use of biomarkers in heart failure with preserved ejection fraction; has received payments for editorial roles from the American Heart Association, the American College of Cardiology, Elsevier, and Wiley, and for academic roles from the University of Texas, Boston University, and Virginia Commonwealth University; and has received research device loans from Atcor Medical, Fukuda-Denshi, Unex, Uscom, NDD Medical Technologies, Microsoft, and MicroVision Medical. The remaining authors have nothing to disclose.
Comment in
-
The Geometry of Aging: New Angles on Cardiovascular Risk.Circulation. 2025 Sep 16;152(11):762-764. doi: 10.1161/CIRCULATIONAHA.125.076185. Epub 2025 Sep 15. Circulation. 2025. PMID: 40953140 No abstract available.
References
-
- Olsen MH, Angell SY, Asma S, Boutouyrie P, Burger D, Chirinos JA, Damasceno A, Delles C, Gimenez-Roqueplo A-P, Hering D, et al. A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension. The Lancet. 2016;388:2665–2712. doi: 10.1016/S0140-6736(16)31134-5 - DOI - PubMed
-
- Redheuil A, Yu W-C, Mousseaux E, Harouni AA, Kachenoura N, Wu CO, Bluemke D, Lima JAC. Age-Related Changes in Aortic Arch Geometry: Relationship With Proximal Aortic Function and Left Ventricular Mass and Remodeling. Journal of the American College of Cardiology. 2011;58:1262–1270. doi: 10.1016/j.jacc.2011.06.012 - DOI - PMC - PubMed
MeSH terms
Grants and funding
- R01 HL137984/HL/NHLBI NIH HHS/United States
- R01 HL155599/HL/NHLBI NIH HHS/United States
- UL1 TR001878/TR/NCATS NIH HHS/United States
- R03 HL146874/HL/NHLBI NIH HHS/United States
- R01 HL104106/HL/NHLBI NIH HHS/United States
- R01 HL121510/HL/NHLBI NIH HHS/United States
- R56 HL136730/HL/NHLBI NIH HHS/United States
- R01 AG058969/AG/NIA NIH HHS/United States
- R01 HL153646/HL/NHLBI NIH HHS/United States
- R33 HL146390/HL/NHLBI NIH HHS/United States
- R01 EB031722/EB/NIBIB NIH HHS/United States
- R01 HL133889/HL/NHLBI NIH HHS/United States
- R01 HL155764/HL/NHLBI NIH HHS/United States
- U01 TR003734/TR/NCATS NIH HHS/United States
- P01 HL094307/HL/NHLBI NIH HHS/United States
- R01 HL157108/HL/NHLBI NIH HHS/United States
- P41 EB029460/EB/NIBIB NIH HHS/United States
- K24 AG070459/AG/NIA NIH HHS/United States
- R01 HL169378/HL/NHLBI NIH HHS/United States
- U01 HL160277/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
